Advanced glycation end products (AGEs)-induced expression of TGF-β1 is suppressed by a protease in the tubule cell line LLC-PK1

Nephrology Dialysis Transplantation

Volumn 16, Issue 8, 2001, Pages 1562-1569

  Xiang, Guangsheng ^a   Schinzel, Reinhard ^a   Simm, Andreas ^a   Münch, Gerald ^a   Sebekova, Katarina ^b   Kasper, Michael ^c   Niwa, Toshimitsu ^e   Schmitz, Christoph ^d   Heidland, August ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

AGEs; Cell proliferation; Imidazolone; TGF 1 mRNA; Trypsin and tubule cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BINDING PROTEIN; BOVINE SERUM ALBUMIN; CELL PROTEIN; IMIDAZOLONE; PROTEINASE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL COUNT; CELL LINE; CELL PROLIFERATION; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; KIDNEY TUBULE CELL; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034879125     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.8.1562     Document Type: Article

References (35)

1. Structural-functional correlations of diabetic nephropathy
2. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-beta as a key mediator
3. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
4. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestation of renal and retinal disease in diabetes
5. Immunocytochemical detection of advanced glycation end products in rat renal tissue as a function of age and diabetes
6. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease
7. Advanced glycosylation end products induce glomerular sclerosis and albuminuria in normal rats
8. Review AGEs and their interaction with AGE-receptors in vascular disease and diabetes
9. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface
10. Receptors for advanced glycation end products (AGE)-expression by endothelial cells in nondiabetic uraemic patients
11. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose
12. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding
13. Mechanism of the inhibitory effect of OPB-9195 [(±)-2-isopropylidenehydrazono-4-oxothiazolidin-5-ylacetanilide] on advanced glycation end product and advanced lipoxidation end product formation
14. An agent cleaving glucose-derived derived protein crosslinks in vitro and in vivo
15. Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesanglial cells
16. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products
17. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
18. Transforming growth factor-β in tissue fibrosis
19. 1 on cathepsin activity in cultured tubule cells
20. 1
21. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients
22. Measurement of protein using bicinochoninic acid
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. Monitoring mRNA expression by polymerase chain reaction: The 'primer-droping' method
25. Sequence of the porcine transforming growth factor-beta precursor
26. High glucose induced proliferation in mesangial cells is reversed by autocrine TGF-β
27. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients
28. No difference between estimated mean nuclear volumes of various types of neurons in the mouse brain obtained on either isotropic uniform random sections or conventional frontal or sagittal sections
29. Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells
30. Advanced glycation end products modulate transcriptional regulation in mesangial cells
31. Toxic action of advanced glycation end-products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy
32. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products
33. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease
34. Advanced glycation end-products stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1
35. Paradoxical effects of a synthetic metalloproteinases inhibitor that blocks both P55 and P75 TNF receptor shedding and TNF-α processing in RA synovial membrane cell cultures